U.S. markets close in 5 hours 24 minutes
  • S&P 500

    3,903.23
    -20.45 (-0.52%)
     
  • Dow 30

    31,171.08
    -318.99 (-1.01%)
     
  • Nasdaq

    11,440.65
    +22.49 (+0.20%)
     
  • Russell 2000

    1,779.26
    +4.41 (+0.25%)
     
  • Crude Oil

    108.51
    -1.08 (-0.99%)
     
  • Gold

    1,841.90
    +26.00 (+1.43%)
     
  • Silver

    21.88
    +0.33 (+1.54%)
     
  • EUR/USD

    1.0570
    +0.0104 (+0.99%)
     
  • 10-Yr Bond

    2.8320
    -0.0540 (-1.87%)
     
  • GBP/USD

    1.2487
    +0.0144 (+1.17%)
     
  • USD/JPY

    127.3400
    -0.9570 (-0.75%)
     
  • BTC-USD

    29,808.63
    +443.85 (+1.51%)
     
  • CMC Crypto 200

    662.90
    +10.67 (+1.64%)
     
  • FTSE 100

    7,285.60
    -152.49 (-2.05%)
     
  • Nikkei 225

    26,402.84
    -508.36 (-1.89%)
     

'We’re generally aligned with Biden' on U.S. drug pricing reform: GoodRx Co-CEO

In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Doug Hirsch, GoodRx Co-CEO & Co-Founder, joins Yahoo Finance Live to discuss the company's second-quarter financial results and break down where GoodRx stands on Biden’s call to Congress to lower prescription drug costs.